Evidence map›Paper›PMID 42045856›Full record

ArticleBMC neurology2026

A case of novel meningoencephalomyelitis associated with vimentin IgG autoantibodies.

Yi Sun, Zijie Cao, Fengling Li

Abstract readCase Reports
In one paragraph

Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yi SunAffiliated Hospital of Shandong Second Medical University, No. 2428, Yuhe Road, Kuiwen District, Weifang City, 261000, China.
Zijie CaoCapital Medical University, School of Rehabilitation, No. 10, Jiaomen North Road, Fengtai District, Beijing, 100069, China.
Fengling LiAffiliated Hospital of Shandong Second Medical University, No. 2428, Yuhe Road, Kuiwen District, Weifang City, 261000, China. lifenglinglfl@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vimentin IgG-related encephalomyelitis is a potentially novel meningoencephalomyelitis syndrome associated with autoantibodies against Vimentin. It was first studied and named by Professor Hao Junwei et al. in 2025. There are currently no other reports at home and abroad. Vimentin IgG-related encephalomyelitis is characterized by recurrent symptoms (mainly manifested as cerebellar ataxia and rhombencephalitis), bilateral corticospinal tract (CST) lesions, intrathecal IgG synthesis, and the presence of Vimentin IgG in cerebrospinal fluid (CSF). Its onset is related to Vimentin. This study reports a case of Vimentin IgG-related encephalomyelitis admitted to our hospital as follows.

Indexed as

AutoantibodiesEncephalomyelitisImmunoglobulin GMeningoencephalitisVimentinHumansMaleAutoantibodiesImmunoglobulin GVimentinMagnetic resonance imagingMeningoencephalomyelitisVimentin

Identifiers

PMID42045856
PMCPMC13267215

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.